medical device technology News
-
ABK Biomedical Inc. Appoints Michael J. Mangano as President and CEO
ABK Biomedical announced today the appointment of Michael J. Mangano as president and chief executive officer. Mangano will be responsible for leading global business activities, including the rapid development, regulatory approval and commercialization of ABK’s unique medical device technologies. Mangano most recently served as president and CEO of ReShape Medical, a U.S. venture-backed ...
-
Xeltis receives €15M funding from EIC Accelerator
Xeltis will receive €15 million in funding from the European Innovation Council Accelerator (EIC) set up by the European Commission. The EIC funding comprises €2.5 millions in grants and up to €12.5 millions in equity and will support Xeltis’ clinical trial program for its XABG device, the first-ever restorative Coronary Artery Bypass Graft (CABG). XABG is a restorative, ...
By XELTIS BV
-
Appointment of Patryk Kania as CEO of Field Orthopaedics
Field Orthopaedics is pleased to announce that Patryk Kania has been appointed as the Company’s new Chief Executive Officer (CEO), succeeding Dr Christopher Jeffrey, who stepped aside as CEO and Board member by mutual agreement earlier this year. Patryk has been acting as CEO while the Board worked through Dr Jeffery’s contractual release, which has only just been ...
-
Aatru Medical, LLC submits NPSIMS product to FDA for Class II Clearance and completes Series C funding
Aatru Medical, LLC ("Aatru") is pleased to announce its recent submission to the FDA of a traditional 510(k) premarket notification application for the company's first product, NPSIMS - Negative Pressure Surgical Incision Management System. The submission efforts were led by Aatru President and Board Member Edward Armstrong, in conjunction with Coastal Consulting Group, NAMSA, and DuVal & ...
-
7th Annual Africa Hospital Expansion Summit
Africa has made considerable progress in improving their health outcomes, despite all the different challenges encountered by the countries. Indicators such as life expectancy and infant mortality improving by the day and showing the efforts of the Governments towards a healthier population. However, there is still a lot to do, since healthcare access in Africa is still constrained by criteria ...
-
3rd Annual Latin America Hospital Expansion Summit
After two successful editions of the Latin America Hospital Expansion Summit, Lnoppen will be hosting the 3rd Annual Latin America Hospital Expansion Summit in San Jose, Costa Rica on September 13th and 14th 2018. Costa Rica is investing over 1 billion dollars for upgrading existing facilities like the Hospital de las Mujeres, Hospital de Niños and Centro Psiquiatrico Penitenciario. These ...
-
4th Annual Latin America Hospital Expansion
Chile will invest around 10 billion dollars to improve its hospital infrastructure. The country plans to have 25 hospitals finished between 2018 - 2020 and launch another 25 hospitals in feasibility study, design and tender phases. The investments include the acquisition of cutting-edge technology and will be creating 74.000 jobs per year throughout Chile. In the entire region, investments in ...
-
Winner at the 2020 Med-Tech Awards - Numedico
It is with pleasure that we can announce that Numedico Technologies has been nominated as a winner in the 2020 Global Med-Tech Awards. Announced this week, Global Health and Pharma Magazine published the results of the 3rd annual MedTech Awards. This year the GHP News Medtech Awards 2020, celebrated those who have demonstrated an ability to innovate in this industry. Shining in this dynamic ...
-
Aatru Medical Announces FDA Clearance and Commercial Launch of the NPSIMS - Negative Pressure Surgical Incision Management System
Aatru Medical, LLC ("Aatru") today announced U.S. Food and Drug Administration (FDA) 510(k) Class II clearance of the NPSIMS™ Negative Pressure Surgical Incision Management System. The NPSIMS utilizes an innovative mode-of-action that eliminates the expensive electromechanical pump, battery, and electronics found in most other negative pressure wound therapy (NPWT) systems being deployed ...
-
US. Sen. Tammy Baldwin visits Attwill Medical Solutions
Attwill Medical Solutions was proud to host U.S. Senator Tammy Baldwin (D-WI) today for a. roundtable discussion regarding the company, as well as a comprehensive factory tour. Attwill Medical. Solutions is one of the largest manufacturers of reagents for COVID-19 and other PCR testing kits, and. has unique freeze-drying technology, which may be utilized for the development of vaccines in a pill. ...
-
Synaptive Medical Announces Timothy J. Scannell as New Chair of Board of Directors
Synaptive Medical, a global medical device and technology company solving surgical, imaging and data challenges, is pleased to announce the appointment of Timothy J. Scannell as the new Chair of the Board of Directors, effective June 20, 2023. Mr. Scannell joined Synaptive Medical’s Board of Directors in August 2022, bringing a wealth of experience and expertise in the medical device ...
-
Aatru Medical Abstract Accepted for Presentation in Two Leading 2020 Wound Healing Conferences
Aatru Medical, LLC ("Aatru") announced today that its technical Abstract has been accepted for presentation at both the SAWC/WHS 2020 conference in North Carolina and also at EWMA 2020, to be held in London, England. The 2020 Symposium on Advanced Wound Care (SAWC)/Wound Healing Society (WHS) meeting is the largest gathering of wound care professionals in the US. The European Wound Management ...
-
Distalmotion announces Todd M. Pope as new board member
Distalmotion announced today the appointment of Todd M. Pope, Operating Partner at Revival Healthcare Capital, Vice Chairman of the WellAir Group and Chairman of Advamed Accel to the Distalmotion Board of Directors. The Distalmotion board is chaired by Rick Anderson, Chairman of Revival Healthcare Capital. “We are delighted to welcome Todd Pope to the Distalmotion Board of ...
-
Medical Device Company Lazurite™ to Relocate its Headquarters to Accommodate Growth
Medical device and technology company Lazurite Holdings LLC announced today the relocation and expansion of its headquarters from Cleveland to a new office space in suburban Warrensville Heights, Ohio, to advance the operations and growth of the company. The new office space is located at 4700 Richmond Road. Lazurite is relocating from its office in Cleveland to a new, larger space in suburban ...
-
Frost & Sullivan awards N8 Medical New Product Innovation Award for its Platform Medical Device Technology to Prevent Hospital-Acquired Infections
N8 Medical, LLC (N8 Medical) today announced it has been selected as the winner of a North American New Product Innovation Award by Frost & Sullivan, a leader in global research and consulting solutions. N8 Medical is developing disruptive medical devices that prevent hospital-acquired infections and their expensive and potentially fatal consequences. N8 Medical earned the award for its ...
-
Carlsmed and the International Spine Study Group Foundation Announce Long-term Partnership
CARLSBAD, Calif.--(BUSINESS WIRE)--Carlsmed, Inc., a commercial stage medical device technology company, is announcing today that it has partnered with the International Spine Study Group Foundation (ISSGF), the premier study group on adult spinal deformity, to collect data on surgical treatment with personalized interbody devices. Long term outcomes data will be collected to assess the role of ...
-
Argon Medical Devices Acquires Three Technologies from Rex Medical
PLANO, Texas, Jan. 5, 2016 /PRNewswire/ -- Argon Medical Devices, Inc. announced the completed acquisition of three vascular products from Rex Medical, LLC. The OptionELITE™ Retrievable Vena Cava Filter, CLEANER™ Rotational Thrombectomy System, and UltraStream™ Chronic Hemodialysis Catheter are now wholly owned by Argon Medical Devices, Inc. Prior to this transaction, ...
-
Neuspera Medical Receives Investigational Device Exemption for Its Ultra-Miniaturized Implantable Device
Neuspera Medical Inc., a clinical stage, private, venture capital backed neuromodulation company, announced the receipt of an Investigational Device Exemption (IDE) from the FDA – enabling the company to conduct the first long-term clinical trial of its ultra-miniaturized neuromodulation platform. An MRI Conditional version of Neuspera’s wirelessly powered implant designed for use as ...
-
Neuspera Announces Leadership Expansion with the Addition of New CFO and CMO
Neuspera Medical, a medical device company developing implantable medical device technology for patients battling chronic illness, today announced the hiring of industry veterans Melissa Farina as Chief Financial Officer and Steven Siegel, MD, as Chief Medical Officer. Farina and Siegel have joined Neuspera as the company recently began enrollment of the second phase of their pivotal clinical ...
-
Aatru Medical Announces Clinical Study and Interim Analysis of their NPSIMS Negative Pressure Surgical Incision Management System
Aatru Medical, LLC ("Aatru") today announced the successful completion of the first 14 patients in their multi-center New Zealand-based clinical study of the FDA-approved NPSIMS™ Negative Pressure Surgical Incision Management System. The full Study enrollment will include plastic surgery, spinal surgery and cardiothoracic surgery closed incisions. The NPSIMS™, which contains no ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you